Growth Metrics

Staar Surgical (STAA) Capital Expenditures (2016 - 2026)

Staar Surgical's Capital Expenditures history spans 17 years, with the latest figure at $1.7 million for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 70.71% year-over-year to $1.7 million; the TTM value through Jan 2026 reached $5.8 million, down 75.12%, while the annual FY2026 figure was $5.8 million, 75.12% down from the prior year.
  • Capital Expenditures reached $1.7 million in Q1 2026 per STAA's latest filing, up from $883000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $9.2 million in Q3 2023 to a low of $883000.0 in Q3 2025.
  • Average Capital Expenditures over 5 years is $4.1 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: surged 106.9% in 2024, then crashed 85.83% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $4.0 million in 2022, then dropped by 23.28% to $3.1 million in 2023, then soared by 85.4% to $5.7 million in 2024, then plummeted by 84.58% to $883000.0 in 2025, then surged by 89.92% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Capital Expenditures are $1.7 million (Q1 2026), $883000.0 (Q3 2025), and $1.8 million (Q2 2025).